Nornostocine congeners as potential anticancer drugs: An overview

被引：13
|
作者：
Sahoo, Chita R. [1 ,2 ,3 ]
Paidesetty, Sudhir K. [3 ]
Padhy, Rabindra N. [1 ,2 ]
机构：
[1] Siksha O Anusandhan Deemed Be Univ, Inst Med Sci, Cent Res Lab, Bhubaneswar 751003, Odisha, India
[2] Siksha O Anusandhan Deemed Be Univ, Sum Hosp, Bhubaneswar 751003, Odisha, India
[3] Siksha O Anusandhan Deemed Be Univ, Sch Pharmaceut Sci, Dept Med Chem, Bhubaneswar 751003, Odisha, India
来源：
DRUG DEVELOPMENT RESEARCH | 2019年 / 80卷 / 07期
关键词：
antiproliferation; cyanobacteria; pyrazolo[4; 3-e][1; 2; 4] triazole; SAR; SILDENAFIL ANALOGS; NOSTOCINE-A; SULFONAMIDES; TYROSINASE;
D O I：
10.1002/ddr.21577
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The naturally occurring phyco-constituent nostocine A, bearing the pyrazolotriazine scaffold in its structural frame, belongs to an organic class of pharmacologically curious candidates with a remarkable anticancer activity. This review summarizes the chemistry of numerous synthetic strategies of demethylated nostocine as "nornostocine derivatives," in which the substitutes are connected to a few functionalities with the pyrazolotriazine moiety at N-1, C-3, and C-5 positions. These strategies may provide a framework to design and develop a novel potent anticancer drug candidate(s) with an augment of structure activity relationship related to anticancer activities.
引用
收藏
页码：878 / 892
页数：15
相关论文
共 50 条
  • [41] Ferrocenes as potential anticancer drugs. Facts and hypotheses
    Babin, V. N.
    Belousov, Yu. A.
    Borisov, V. I.
    Gumenyuk, V. V.
    Nekrasov, Yu. S.
    Ostrovskaya, L. A.
    Sviridova, I. K.
    Sergeeva, N. S.
    Simenel, A. A.
    Snegura, L. V.
    RUSSIAN CHEMICAL BULLETIN, 2014, 63 (11) : 2405 - 2422
  • [42] Norharmane as a potential chemical entity for development of anticancer drugs
    Sahoo, Chita Ranjan
    Paidesetty, Sudhir Kumar
    Padhy, Rabindra Nath
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 162 : 752 - 764
  • [43] Ferrocenes as potential anticancer drugs. Facts and hypotheses
    V. N. Babin
    Yu. A. Belousov
    V. I. Borisov
    V. V. Gumenyuk
    Yu. S. Nekrasov
    L. A. Ostrovskaya
    I. K. Sviridova
    N. S. Sergeeva
    A. A. Simenel
    L. V. Snegur
    Russian Chemical Bulletin, 2014, 63 : 2405 - 2422
  • [44] Melatonin May Increase Anticancer Potential of Pleiotropic Drugs
    Bojkova, Bianka
    Kubatka, Peter
    Qaradakhi, Tawar
    Zulli, Anthony
    Kajo, Karol
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [45] Possible potential of Astrodaucus genus in development of anticancer drugs
    Hesari, Narges Ghorbani
    Tofighi, Zahra
    Shirmardi, Seyedeh Fatemeh
    Hashemi, Seyed Mostafa
    Hadjiakhoondi, Abbas
    Goodarziz, Saied
    AVICENNA JOURNAL OF PHYTOMEDICINE, 2021, 11 (01) : 11 - 21
  • [46] Calixpyrroles: from Anion Ligands to Potential Anticancer Drugs
    Kohnke, Franz H.
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2020, 2020 (28) : 4261 - 4272
  • [47] Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugs
    Allen, Olivia R.
    Knox, Richard J.
    McGowan, Patrick C.
    DALTON TRANSACTIONS, 2008, (39) : 1293 - 1295
  • [48] Potential anticancer role of colchicine-based derivatives: an overview
    Kumar, Ashok
    Sharma, Parduman R.
    Mondhe, Dilip M.
    ANTI-CANCER DRUGS, 2017, 28 (03) : 250 - 262
  • [49] Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors
    Sathish, Manda
    Kavitha, Botla
    Nayak, V. Lakshma
    Tangella, Yellaiah
    Ajitha, Ayyappan
    Nekkanti, Shalini
    Alarifi, Abdullah
    Shankaraiah, Nagula
    Nagesh, Narayana
    Kamal, Ahmed
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 144 : 557 - 571
  • [50] In the search for new anticancer drugs. 29. A study on the correlation of lipophilicities, ionization constants and anticancer activities of aminoxyl labeled TEPA congeners
    Sosnovsky, G
    Bell, P
    LIFE SCIENCES, 1998, 62 (07) : 639 - 648
12345